BRIEF published on 11/13/2024 at 18:25, 7 days 19 hours ago Morgan Stanley Increases Stake in Halfords Group Voting Rights Financial Announcement Morgan Stanley Share Acquisition Halfords Group
PRESS RELEASE published on 11/13/2024 at 18:20, 7 days 19 hours ago Halfords Group PLC: Holding(s) in Company* Morgan Stanley discloses a 6.29% stake in Halfords Group PLC through acquired voting rights on 08-Nov-2024 Acquisition Voting Rights Halfords Group PLC Morgan Stanley 6.29%
BRIEF published on 11/13/2024 at 15:01, 7 days 23 hours ago Halfords Group PLC to Release Interim Results Motoring Services SaaS Solutions Halfords Interim Results Cycling Products
PRESS RELEASE published on 11/13/2024 at 14:56, 7 days 23 hours ago Halfords Group PLC: Notice of Interim Results announcement Halfords Group PLC to announce interim results for 26 weeks ending 27 September 2024 on 26 November 2024. Leading provider of motoring and cycling services in the UK UK Halfords Interim Results Motoring Cycling
BRIEF published on 10/31/2024 at 16:50, 20 days 21 hours ago Halfords Group PLC Announces Total Voting Rights Update Share Capital Voting Rights FCA Rules Disclosure Guidance Halfords Group
PRESS RELEASE published on 10/31/2024 at 16:45, 20 days 21 hours ago Halfords Group PLC: Total Voting Rights Halfords Group PLC announces total voting rights as 218,928,736 ordinary shares of 1p each with equal voting rights and no shares in Treasury Share Capital Halfords Group PLC Total Voting Rights Disclosure Rules Company Secretary
BRIEF published on 10/22/2024 at 08:05, 30 days 6 hours ago Halfords Group PLC Reports Stable Sales in Challenging Market Strategic Progress Consumer Sentiment Halfords Sales Performance Retail And Autocentres
PRESS RELEASE published on 10/22/2024 at 08:00, 30 days 6 hours ago Halfords Group PLC: Trading update for the 26 weeks to 27 September 2024 Halfords Group PLC reports trading update for the 26 weeks to 27 September 2024, with a strategy delivering to plan, flat like-for-like sales, and focus on cost savings and strategic progress Halfords Group PLC Trading Update Cost Savings Strategic Progress Flat Sales
BRIEF published on 10/01/2024 at 16:11, 1 month 19 days ago Halfords Group PLC: Significant Shareholding Update Voting Rights Shareholding Financial Update Halfords Group Gresham House
PRESS RELEASE published on 10/01/2024 at 16:06, 1 month 19 days ago Halfords Group PLC: Holdings in Company Gresham House Asset Management Limited discloses holding 10.24% of voting rights in Halfords Group PLC (HFD) as of 26-Sept-2024 Voting Rights Major Holdings Notification HFD Halfords Group PLC Gresham House Asset Management Limited
Published on 11/21/2024 at 13:30, 35 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 35 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 30 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 50 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 7 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 45 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
